Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junbo Ge

Showing results (321-330 of 1,298) with videos related to

Pageof 130
Sort By:
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2018
Antagonism of receptor interacting protein 1 using necrostatin-1 in oxidized LDL- induced endothelial injurySongtao An, Yanyan Qi, Zhiguo Zhang, et al.
Journal of Cardiovascular Pharmacology|March 4, 2021
Shexiang Baoxin Pill Attenuates Ischemic Injury by Promoting Angiogenesis by Activation of Aldehyde Dehydrogenase 2Jingjing Hu, Yongchao Zhao, Yonghui Wu, et al.
International Journal of Cardiology|September 15, 2012
Besides CYP2C19, PON1 genetic variant influences post-clopidogrel platelet reactivity in Chinese patientsHongyi Wu, Juying Qian, Jianfeng Xu, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 19, 2024
TRIM25-mediated XRCC1 ubiquitination accelerates atherosclerosis by inducing macrophage M1 polarization and programmed deathHongxian Wu, Wei Gao, Yuanji Ma, et al.
European Journal of Medical Research|January 16, 2023
Treatment strategy for spontaneous coronary artery dissection based on anatomical characteristicsYuanji Ma, Xin Zhong, Jiasheng Yin, et al.
Cell Death & Disease|December 5, 2022
FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFMYaguang Bi, Haixia Xu, Xiang Wang, et al.
Biochemical and Biophysical Research Communications|January 26, 2020
Overexpression of COX5A protects H9c2 cells against doxorubicin-induced cardiotoxicityPeipei Zhang, Zhangwei Chen, Danbo Lu, et al.
Journal of Cardiovascular Translational Research|March 27, 2020
D-Dimer Level Predicts Angiographic No-Reflow Phenomenon After Percutaneous Coronary Intervention Within 2-7 Days of Symptom Onset in Patients with ST-Segment Elevation Myocardial InfarctionXue Gong, Xiaoting Lei, Zheyong Huang, et al.
Journal of Cardiovascular Translational Research|March 29, 2020
Correction to: MGUS Predicts Worse Prognosis in Patients with CoronaryArtery DiseaseZhao Xu, Yifeng Sun, Tianhong Xu, et al.
Pacing and Clinical Electrophysiology : PACE|April 1, 2018
Atrial transseptal left ventricular lead implantation for cardiac resynchronization therapy using arteriovenous loop techniqueYixiu Liang, Daxin Zhou, Jingfeng Wang, et al.
Pageof 130

Showing results (321-330 of 1,298) with videos related to

Sort By:
Pageof 130
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2018
Antagonism of receptor interacting protein 1 using necrostatin-1 in oxidized LDL- induced endothelial injurySongtao An, Yanyan Qi, Zhiguo Zhang, et al.
Journal of Cardiovascular Pharmacology|March 4, 2021
Shexiang Baoxin Pill Attenuates Ischemic Injury by Promoting Angiogenesis by Activation of Aldehyde Dehydrogenase 2Jingjing Hu, Yongchao Zhao, Yonghui Wu, et al.
International Journal of Cardiology|September 15, 2012
Besides CYP2C19, PON1 genetic variant influences post-clopidogrel platelet reactivity in Chinese patientsHongyi Wu, Juying Qian, Jianfeng Xu, et al.
Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 19, 2024
TRIM25-mediated XRCC1 ubiquitination accelerates atherosclerosis by inducing macrophage M1 polarization and programmed deathHongxian Wu, Wei Gao, Yuanji Ma, et al.
European Journal of Medical Research|January 16, 2023
Treatment strategy for spontaneous coronary artery dissection based on anatomical characteristicsYuanji Ma, Xin Zhong, Jiasheng Yin, et al.
Cell Death & Disease|December 5, 2022
FUNDC1 protects against doxorubicin-induced cardiomyocyte PANoptosis through stabilizing mtDNA via interaction with TUFMYaguang Bi, Haixia Xu, Xiang Wang, et al.
Biochemical and Biophysical Research Communications|January 26, 2020
Overexpression of COX5A protects H9c2 cells against doxorubicin-induced cardiotoxicityPeipei Zhang, Zhangwei Chen, Danbo Lu, et al.
Journal of Cardiovascular Translational Research|March 27, 2020
D-Dimer Level Predicts Angiographic No-Reflow Phenomenon After Percutaneous Coronary Intervention Within 2-7 Days of Symptom Onset in Patients with ST-Segment Elevation Myocardial InfarctionXue Gong, Xiaoting Lei, Zheyong Huang, et al.
Journal of Cardiovascular Translational Research|March 29, 2020
Correction to: MGUS Predicts Worse Prognosis in Patients with CoronaryArtery DiseaseZhao Xu, Yifeng Sun, Tianhong Xu, et al.
Pacing and Clinical Electrophysiology : PACE|April 1, 2018
Atrial transseptal left ventricular lead implantation for cardiac resynchronization therapy using arteriovenous loop techniqueYixiu Liang, Daxin Zhou, Jingfeng Wang, et al.
Pageof 130